“Her Life,
Our Mission.”
The First Global Women’s Health Solution Company.
Who We Are
Empower Women to Live Their Best Life
- A more accurate and earlier diagnosis to enable proactive disease management and avoid anxiety
- A better treatment without the hormone and antibiotic side effects
- A more informed journey toward a better chance for a successful pregnancy
Challenges in Women’s Health
Complicated and Heterogeneous Disease
In addition to the heterogeneity across individuals, many health disorders affecting women are heterogeneous and complicated, involving numerous organs and hormone pathways.
Social Stigma and Low Awareness
Long-existing social stigma has
kept women silent. Combined with
low awareness of these health conditions, women are led to believe that they are fine and to
accept the condition as “normal”.
Lack of True Innovation
The diagnostic and therapeutic
options for women’s health
conditions are outdated; e.g., for
women with endometriosis,
surgery is currently the gold
standard for disease diagnosis,
and treatment is limited to
hormonal therapy.
Major Women’s Health Conditions
General Women’s Health
Reproductive Health
Pregnancy
Menopause
Conditions Unique to Women
- Female contraceptive
- Endometriosis
- Female fertility
- Pre-term birth
- Postpartum hemorrhage
- Preeclampsia
- Vaginitis
- Fibroids and abnormal uterine bleeding (AUB)
- Dysmenorrhea
- Polycystic ovary syndrome
- Female sexual function
- Peripartum cardiomyopathy
- Vasomotor symptoms (Hot flash)
- Postpartum depression (PPD)
Conditions Disproportionately Impacting Women
- Osteoporosis
- Urinary tract infections
- Incontinence
- HPV
- Anxiety
- Migraine
- Overactive bladder (OAB)
- Lupus
- Anemia
- Thyroid disorders
- Celiac disease
Our Areas of Focus
Endometriosis (Endo)
Endometriosis is a leading debilitating and systemic
disease that affects the quality of life for women
worldwide with a broad spectrum of physical and
psychological symptoms.
Endometriosis is a disease where tissue similar to the lining of the uterus grows in other places in a woman’s body, causing pain, an increased risk for infertility, and chronic inflammation.
It is a very heterogeneous disease in terms of symptoms, treatment responsiveness, and the presentation of endometriotic lesions, making timely diagnosis and treatment extremely challenging.
Female Fertility
Infertility is a highly prevalent condition globally, and the infertility rate has been continuously growing.
Infertility is defined as the failure to achieve a pregnancy after ≥12 months of regular unprotected sexual intercourse (WHO).
Women’s disorders caused ~40% of infertility cases. Some of the leading diseases include endometriosis (20-50%) [1], PCOS (30-60%) [2], fibroids (5-10%) [3], pelvic inflammatory disease, and others. BV is also prevalent among infertile women (10-20%) [4] and is a leading cause of adverse pregnancy outcomes.
Bacterial Vaginosis (BV)
BV is the most common vaginal infection among reproductive-age women, with >110 Mn patients worldwide.
BV is a common type of vaginal inflammation, causing considerable physical and psychosocial discomfort and is associated with an increased risk of multiple adverse outcomes, including preterm birth, pelvic inflammatory disease, endometritis, and transmission and acquisition of HIV-1 and STD.
It is now understood that BV is caused by vagina dysbiosis – the overgrowth of anaerobic bacteria that disrupts healthy vaginal flora, which is dominated by hydrogen peroxide and lactic acid-producing Lactobacillus species.
Our Areas of Focus
Endometriosis (Endo)
Endometriosis is a leading debilitating and systemic
disease that affects the quality of life for women
worldwide with a broad spectrum of physical and
psychological symptoms.
Endometriosis is a disease where tissue similar to the lining of the uterus grows in other places in a woman’s body, causing pain, an increased risk for infertility, and chronic inflammation.
It is a very heterogeneous disease in terms of symptoms, treatment responsiveness, and the presentation of endometriotic lesions, making timely diagnosis and treatment extremely challenging.
Bacterial Vaginosis (BV)
BV is the most common vaginal infection among reproductive-age women, with >110 Mn patients worldwide.
BV is a common type of vaginal inflammation, causing considerable physical and psychosocial discomfort and is associated with an increased risk of multiple adverse outcomes, including preterm birth, pelvic inflammatory disease, endometritis, and transmission and acquisition of HIV-1 and STD.
It is now understood that BV is caused by vagina dysbiosis – the overgrowth of anaerobic bacteria that disrupts healthy vaginal flora, which is dominated by hydrogen peroxide and lactic acid-producing Lactobacillus species.
Female Fertility
Infertility is a highly prevalent condition globally, and the infertility rate has been continuously growing.
Infertility is defined as the failure to achieve a pregnancy after ≥12 months of regular unprotected sexual intercourse (WHO).
Women’s disorders caused ~40% of infertility cases. Some of the leading diseases include endometriosis (20-50%) [1], PCOS (30-60%) [2], fibroids (5-10%) [3], pelvic inflammatory disease, and others. BV is also prevalent among infertile women (10-20%) [4] and is a leading cause of adverse pregnancy outcomes.
Stress Urinary Incontinence (SUI)
SUI is a highly prevalent disease, impacting >330Mn women’s quality of life globally.
SUI is the most common type of urinary incontinence in women, which is an involuntary leakage of urine during moments of certain physical activity when abdominal pressure increases, such as coughing, sneezing, laughing, or exercising.
However, most patients are silently suffering and not actively seeking treatment largely due to a sense of shame, lack of awareness of treatment options, affordability limits, or consider SUI as a natural consequence of aging.
Sources
[1]. 子宫内膜异位症诊治指南（第三版）
[2]. 多囊卵巢综合征的诊治进展 2020
[3]. Guo XC, Segars JH. The impact and management of fibroids for fertility: an evidence-based approach. Obstet Gynecol Clin North Am. 2012 Dec;39(4):521-33
[4]. Van Oostrum N, et al, Risks associated with bacterial vaginosis in infertility patients: a systematic review and meta-analysis. Hum Reprod. 2013 Jul;28(7):1809-15
